Previous Close | 43.35 |
Open | 43.48 |
Bid | 43.82 x 3000 |
Ask | 43.83 x 3200 |
Day's Range | 43.41 - 43.95 |
52 Week Range | 37.80 - 46.97 |
Volume | |
Avg. Volume | 5,631,051 |
Market Cap | 110.121B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 19.05 |
EPS (TTM) | 2.30 |
Earnings Date | Feb 01, 2017 - Feb 06, 2017 |
Forward Dividend & Yield | 1.99 (4.59%) |
Ex-Dividend Date | May 19, 2022 |
1y Target Est | 49.81 |
PHILADELPHIA, June 29, 2022--GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
GlaxoSmithKline (GSK) closed the most recent trading day at $43.35, moving -0.8% from the previous trading session.
Gilead (GILD) announces the resubmission of the NDA for lenacapavir, an investigational, long-acting HIV-1 capsid inhibitor, for the treatment of HIV-1 infection in the United States.